These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3854309)

  • 21. Effects of pH on the conformation and activation of plasminogen.
    Takada A; Takada Y
    Thromb Res; 1985 Oct; 40(2):189-97. PubMed ID: 4071469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitation of C3 nephritic factor of alternative complement pathway by an enzyme-linked immunosorbent assay.
    Seino J; Fukuda K; Kinoshita Y; Sudo K; Horigome I; Sato H; Saito T; Furuyama T; Yoshinaga K
    J Immunol Methods; 1987 Dec; 105(1):119-25. PubMed ID: 3680963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Guinea pig antibody to C3 component of the sheep complement produced by immunization with a heat-inactivated sheep serum--alcian blue complex.
    Jonas W; Stankiewicz M
    Arch Immunol Ther Exp (Warsz); 1994; 42(3):193-6. PubMed ID: 7487351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thermal stability and ligand-binding properties of human plasma alpha 1-acid glycoprotein (orosomucoid) as determined with fluorescent probes.
    Busby TF; Ingham KC
    Biochim Biophys Acta; 1986 May; 871(1):61-71. PubMed ID: 2870738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Localized heat urticaria associated with a decrease in serum complement factor B (C3 proactivator).
    Johansson EA; Reunala T; Koskimies S; Lagerstedt A; Kauppinen K; Timonen K
    Br J Dermatol; 1984 Feb; 110(2):227-31. PubMed ID: 6559600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluorometric studies on conformational changes in tropomyosin associated with depolymerization.
    Ohyashiki T; Sekine T
    J Biochem; 1979 Feb; 85(2):575-80. PubMed ID: 422547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of serum factor B, serum opsonins, granulocyte chemotaxis, and infection in nephrotic syndrome of children.
    Anderson DC; York TL; Rose G; Smith CW
    J Infect Dis; 1979 Jul; 140(1):1-11. PubMed ID: 379244
    [No Abstract]   [Full Text] [Related]  

  • 28. Conformational changes associated with the reversible cold inactivation of ribulose-1,5-bisphosphate carboxylase-oxygenase.
    Chollet R; Anderson LL
    Biochim Biophys Acta; 1977 May; 482(1):228-40. PubMed ID: 861231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of alternative pathway and factor B haemolytic activities in patients with systemic lupus erythematosus: correlations with the alternative pathway regulatory proteins.
    Aguado MT; Perrin LH; Ramirez R; Miescher PA; Lambert PH
    Clin Exp Immunol; 1980 Dec; 42(3):495-505. PubMed ID: 6163579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of the C3b binding site in a recombinant vWF-A domain of complement factor B by surface-enhanced laser desorption-ionisation affinity mass spectrometry and homology modelling: implications for the activity of factor B.
    Hinshelwood J; Spencer DI; Edwards YJ; Perkins SJ
    J Mol Biol; 1999 Nov; 294(2):587-99. PubMed ID: 10610782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ciliary dynein conformational changes as evidenced by the extrinsic fluorescent probe 8-anilino-1-naphthalenesulfonate.
    Saucier AC; Mariotti S; Anderson SA; Purich DL
    Biochemistry; 1985 Dec; 24(26):7581-5. PubMed ID: 2936390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of the alternative complement pathway by Fonsecaea pedrosoi.
    Torinuki W; Okohchi K; Takematsu H; Tagami H
    J Invest Dermatol; 1984 Oct; 83(4):308-10. PubMed ID: 6481182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Haemolytic complement activity, C3 and Factor B consumption in serum from chickens divergently selected for antibody responses to sheep red blood cells.
    Parmentier HK; Baelmans R; Nieuwland MG; Dorny P; Demey F
    Vet Immunol Immunopathol; 2002 Nov; 90(1-2):91-100. PubMed ID: 12406658
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SDS denaturation of complement factor C3 as a model for allosteric modifications occurring during C3b binding: demonstration of a profound conformational change by means of circular dichroism and quantitative immunoprecipitation.
    Nilsson B; Nilsson UR
    Immunol Lett; 1986 Aug; 13(1-2):11-4. PubMed ID: 2428739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of iodipamide on human C3 and factor B in vitro.
    Durda PJ; Pagano RJ; Bauman N; Brockman JA
    J Allergy Clin Immunol; 1982 Nov; 70(5):353-60. PubMed ID: 6922882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complement activation by heat-killed human kidney cells: formation, activity, and stabilization of cell-bound C3 convertases.
    Baker PJ; Adler S; Yang Y; Couser WG
    J Immunol; 1984 Aug; 133(2):877-81. PubMed ID: 6376629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activated factor B (Bb) of the alternative pathway of complement activation cleaves and activates plasminogen.
    Sundsmo JS; Wood LM
    J Immunol; 1981 Sep; 127(3):877-80. PubMed ID: 6911148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 1-anilino-8-naphthalene sulfonate as a protein conformational tightening agent.
    Matulis D; Baumann CG; Bloomfield VA; Lovrien RE
    Biopolymers; 1999 May; 49(6):451-8. PubMed ID: 10193192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum heat-labile opsonins in systemic lupus erythematosus.
    Jasin HE; Orozco JH; Ziff M
    J Clin Invest; 1974 Feb; 53(2):343-53. PubMed ID: 11344546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis of complement components (C3, C2, B and C1-inhibitor) and lysozyme by human monocytes and macrophages.
    Lappin D; Hamilton AD; Morrison L; Aref M; Whaley K
    J Clin Lab Immunol; 1986 Jul; 20(3):101-5. PubMed ID: 3638367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.